Network meta-analysis on the efficacy and safety of finerenone versus SGLT2 inhibitors on reducing new-onset of atrial fibrillation in patients with type 2 diabetes mellitus and chronic kidney disease

OBJECTIVE: To evaluate the efficacy and safety of finerenone and sodium-glucose cotransporter-2 inhibitors (SGLT2i) on reducing new-onset of atrial fibrillation (AF) in patients with type 2 diabetes mellitus (T2DM) and chronic kidney disease (CKD). METHOD: We searched the PubMed, Cochrane Library, W...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, Yaofu, Wang, Junheng, Jiang, Li, Wang, Tongxin, Li, Zhuang, Fu, Xiaozhe, Huang, Weijun, Xiao, Yonghua, Wang, Shidong, Zhao, Jinxi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609222/
https://www.ncbi.nlm.nih.gov/pubmed/36303247
http://dx.doi.org/10.1186/s13098-022-00929-3

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9609222/
https://www.ncbi.nlm.nih.gov/pubmed/36303247
http://dx.doi.org/10.1186/s13098-022-00929-3

Ejemplares similares